Patient Retrospective Outcomes (PRO)

Conditions

Chronic Pain

Brief summary

This study will evaluate de-identified (anonymous) data in subject medical charts to review the clinical outcomes of various treatment approaches in the treatment of chronic pain.

Detailed description

This study is a retrospective, multi-center, de-identified patient data review. The study will include multiple independent cohorts to evaluate clinical outcomes in different subgroups.

Ferro R, North J, Kranenburg A, Pyles S, Dorenkamp C, Poston J, Schneider J, Auten K, Goldberg E.

2025-07-03

10.1007/s40122-025-00758-y

Two-year outcomes using fast-acting sub-perception therapy for spinal cord stimulation: results of a real-world multicenter study in the United States

Clark Metzger, Blake Hammond, Richard Ferro, James North, Stephen Pyles et al. (8 authors)

Expert Review of Medical Devices2025-01-166 citations

10.1080/17434440.2025.2453554

B360 Pain relief outcomes using peripheral nerve/field stimulation (PNFS) combined with spinal cord stimulation: a multicenter european evaluation

Paolo Maino, Eva Koetsier, A Wang, Roshini Jain

Chronic Pain & Management2022-06-01

10.1136/rapm-2022-esra.436

ESRA19-0150 Clinical application of an SCS device capable of patient-selective use of multiple available neurostimulative treatment options for chronic pain: real-world outcomes from europe

Pasquale De Negri, MA Canos-Verdecho, L Chen, Roshini Jain

2019-08-30

10.1136/rapm-2019-esraabs2019.102

ESRA19-0137 Two-year follow-up of a customized field shape using sub-perception spinal cord stimulation in a real-world, observational cohort of chronic pain patients

JF Paz-Solis, Que Doan, I Huertas Fernandez, L Chen, Roshini Jain

2019-08-30

10.1136/rapm-2019-esraabs2019.105

Interventions

DEVICENon Boston Scientific Systems

Spinal cord stimulation, RF, IDS etc.

DEVICEBoston Scientific Systems

Spinal cord stimulation, RF, IDS etc

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

No

Inclusion criteria

Key Inclusion Criteria: * Previously treated with or eligible for use with Boston Scientific Systems * 18 years of age or older at the start of Baseline

Design outcomes

Primary

Measure	Time frame	Description
Responder rate	Through study completion, approximately two years	Responder rate for pain relief through study completion.

Countries

Australia, Belgium, France, Germany, Italy, Netherlands, Portugal, Puerto Rico, Spain, Sweden, Switzerland, Turkey (Türkiye), United Kingdom, United States

Contacts

CONTACTAlison Lewis

BSNClinicalTrials@bsci.com855-213-9890

CONTACTCleo Mertz